🇺🇸 FDA
Pipeline program

Liposomal Amphotericin B (LAmB)

Pro00113856

Phase 3 small_molecule active

Quick answer

Liposomal Amphotericin B (LAmB) for Talaromycosis is a Phase 3 program (small_molecule) at Duke University with 1 ClinicalTrials.gov record(s).

Program details

Company
Duke University
Indication
Talaromycosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials